Abstract:Objective: The lack of ressources and coordination to face the epidemic of coronavirus raises concerns for the health of patients with mental disorders in a country where we keep in memory the dramatic experience of famine in psychiatric hospitals during the Second World War. This article aims at proposing guidance to ensure mental health care during the SARS-CoV epidemy in France. Methods: Authors performed a narrative review identifying relevant results in the scientific and medical literature and local initiatives in France. Results: We identified four types of major vulnerabilities in patients suffering from mental disorders during this pandemic: (1) medical comorbidities that are more frequently found in patients suffering from mental disorders (cardiovascular and pulmonary pathologies, diabetes, obesity, etc.) which represent risk factors for severe infections with Covid-19; (2) age (the elderly constituting the population most vulnerable to coronavirus); (3) cognitive and behavioral troubles which can hamper compliance with confinement and hygiene measures and finally and (4) psychosocial vulnerability due to stigmatization and/or socio-economic difficulties. Furthermore, the mental health healthcare system is more vulnerable than other healthcare systems. Current government plans are poorly adapted to psychiatric establishments in a context of major shortage of organizational, material and human resources. In addition, a certain number of structural aspects make the psychiatric institution particularly vulnerable: many beds are closed, wards have a high density of patients, mental health community facilities are closed, medical teams are understaffed and poorly trained to face infectious diseases. We could also face major issues in referring patients with acute mental disorders to intensive care units. To maintain continuity of psychiatric care in this pandemic situation, several directions can be considered, in particular with the creation of Covid+ units. These units are under the dual supervision of a psychiatrist and of an internist/infectious disease specialist; all new entrants should be placed in quarantine for 14 days; the nurse staff should benefit from specific training, from daily medical check-ups and from close psychological support. Family visits would be prohibited and replaced by videoconference. At the end of hospitalization, in particular for the population of patients in compulsory ambulatory care situations, specific case-management should be organized with the possibility of home visits, in order to support them when they get back home and to help them to cope with the experience of confinement, which is at risk to induce recurrences of mental disorders. The total or partial closure of mental health community facilities is particularly disturbing for patients but a regular follow-up is possible with telemedicine and should include the monitoring of the suicide risk and psychoeducation strategies; developing support platforms could also be very helpful in this context. Private psychiatrists have also a crucial role of information with their patients on confinement and barrier measures, but also on measures to prevent the psychological risks inherent to confinement: maintenance of sleep regularity, physical exercise, social interactions, stress management and coping strategies, prevention of addictions, etc. They should also be trained to prevent, detect and treat early warning symptoms of post-traumatic stress disorder, because their prevalence was high in the regions of China most affected by the pandemic. Discussion: French mental healthcare is now in a great and urgent need for reorganization and must also prepare in the coming days and weeks to face an epidemic of emotional disorders due to the containment of the general population.

Characterizing Symptom Profiles in a Military Outpatient Cohort With COVID-19 in the Île-de-France Region

Clinical features of 1487 COVID-19 patients with outpatient management in the Greater Paris: the COVID-call study

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact

A data set of symptoms and needs of individuals affected by COVID-19

Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019

Mental Health Outcomes among Civil Servants Aiding in Coronavirus Disease 2019 Control

Four- and sixteen-month clinical status of a cohort of patients following hospitalization for COVID-19

Mental Health Consequences of the COVID‐19 Outbreak Among Emergency Department Healthcare Workers

Factors associated with psychological symptoms in hospital workers of a French hospital during the COVID-19 pandemic: Lessons from the first wave.

Precision symptom phenotyping identifies early clinical and proteomic predictors of distinct COVID-19 sequelae

Changing characteristics of post-COVID-19 syndrome: Cross-sectional findings from 458 consultations using the Stanford Hall remote rehabilitation assessment tool

Depression and anxiety before and at the beginning of the COVID-19 pandemic and incident persistent symptoms: a prospective population-based cohort study

Psychological Impact of Exposure to the COVID-19 Sanitary Crisis on French Healthcare Workers: Risk Factors and Coping Strategies

Identification of the needs of individuals affected by COVID-19

Profil épidémio-clinique et impact psycho-social des patients hospitalisés au centre de traitement de Covid -19 du CHU Gabriel Touré

Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review

Healthcare associated coronavirus disease 2019 among health care workers in Normandy, France: a multi-center study

Long-term psycho-traumatic consequences of the COVID-19 health crisis among emergency department healthcare workers

[Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review]

Dissecting the association between long COVID and depressive symptoms in a nationally representative population from France

Psychological burden associated with incident persistent symptoms and their evolution during the COVID-19 pandemic: a prospective population-based study